Global Fluorescence-Guided Surgery Systems Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Fluorescence-Guided Surgery Systems market size was valued at US$ 128 million in 2024 and is forecast to a readjusted size of USD 426 million by 2031 with a CAGR of 18.2% during review period.
Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.
The fluorescence-guided surgery (FGS) systems market is primarily driven by the growing demand for more precise and minimally invasive surgical procedures. FGS systems enable surgeons to identify tumors, blood vessels, and other critical structures with high accuracy using fluorescent markers, improving surgical outcomes and reducing complications. The increasing prevalence of cancer worldwide is a key driver, as fluorescence-guided surgery is particularly beneficial in oncology for tumor delineation and complete excision. Additionally, advancements in fluorescence imaging technology, such as higher resolution and improved sensitivity, along with the adoption of robotic-assisted surgeries, further propel market growth. As patients and healthcare providers demand safer, more effective treatments, the market for FGS systems is expected to continue expanding.
However, the market also faces several challenges. One of the primary hurdles is the high cost of fluorescence-guided surgery systems, which can be a barrier to adoption, particularly in low-resource healthcare settings. Additionally, the technology requires specialized training for medical professionals to ensure its proper use, which adds to the operational complexity and costs. The regulatory approval process for fluorescence-based imaging agents can also be lengthy and costly, delaying the introduction of new treatments and technologies. Moreover, the integration of fluorescence-guided surgery systems with existing medical devices and hospital infrastructure can be challenging, limiting their widespread implementation, especially in smaller or less-equipped healthcare facilities.
Global key players of Fluorescence-Guided Surgery Systems include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu and Fluoptics, etc. Top two players occupy for a share about 70%. North America is the largest market, with a share about 63%, followed by Europe and China.
This report is a detailed and comprehensive analysis for global Fluorescence-Guided Surgery Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fluorescence-Guided Surgery Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Fluorescence-Guided Surgery Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Fluorescence-Guided Surgery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Fluorescence-Guided Surgery Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fluorescence-Guided Surgery Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fluorescence-Guided Surgery Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu, Fluoptics, KARL STORZ, Richard Wolf, OptoMedic, Mindray, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fluorescence-Guided Surgery Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Only for Open Surgery
System for Endoscopy
Market segment by Application
Cancer Surgeries
Cardiovascular Surgeries
Others
Major players covered
Stryker
Hamamatsu Photonics
Medtronic
Quest Medical Imaging
Shimadzu
Fluoptics
KARL STORZ
Richard Wolf
OptoMedic
Mindray
Olympus
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fluorescence-Guided Surgery Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fluorescence-Guided Surgery Systems, with price, sales quantity, revenue, and global market share of Fluorescence-Guided Surgery Systems from 2020 to 2025.
Chapter 3, the Fluorescence-Guided Surgery Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fluorescence-Guided Surgery Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fluorescence-Guided Surgery Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fluorescence-Guided Surgery Systems.
Chapter 14 and 15, to describe Fluorescence-Guided Surgery Systems sales channel, distributors, customers, research findings and conclusion.
Fluorescence guided surgery (FGS), (also called 'Fluorescence image-guided surgery', or in the specific case of tumor resection, 'fluorescence guided resection') is a medical imaging technique used to detect fluorescently labelled structures during surgery. Similarly, to standard image-guided surgery, FGS has the purpose of guiding the surgical procedure and providing the surgeon of real time visualization of the operating field. When compared to other medical imaging modalities, FGS is cheaper and superior in terms of resolution and number of molecules detectable.
The fluorescence-guided surgery (FGS) systems market is primarily driven by the growing demand for more precise and minimally invasive surgical procedures. FGS systems enable surgeons to identify tumors, blood vessels, and other critical structures with high accuracy using fluorescent markers, improving surgical outcomes and reducing complications. The increasing prevalence of cancer worldwide is a key driver, as fluorescence-guided surgery is particularly beneficial in oncology for tumor delineation and complete excision. Additionally, advancements in fluorescence imaging technology, such as higher resolution and improved sensitivity, along with the adoption of robotic-assisted surgeries, further propel market growth. As patients and healthcare providers demand safer, more effective treatments, the market for FGS systems is expected to continue expanding.
However, the market also faces several challenges. One of the primary hurdles is the high cost of fluorescence-guided surgery systems, which can be a barrier to adoption, particularly in low-resource healthcare settings. Additionally, the technology requires specialized training for medical professionals to ensure its proper use, which adds to the operational complexity and costs. The regulatory approval process for fluorescence-based imaging agents can also be lengthy and costly, delaying the introduction of new treatments and technologies. Moreover, the integration of fluorescence-guided surgery systems with existing medical devices and hospital infrastructure can be challenging, limiting their widespread implementation, especially in smaller or less-equipped healthcare facilities.
Global key players of Fluorescence-Guided Surgery Systems include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu and Fluoptics, etc. Top two players occupy for a share about 70%. North America is the largest market, with a share about 63%, followed by Europe and China.
This report is a detailed and comprehensive analysis for global Fluorescence-Guided Surgery Systems market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Fluorescence-Guided Surgery Systems market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Fluorescence-Guided Surgery Systems market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Fluorescence-Guided Surgery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2020-2031
Global Fluorescence-Guided Surgery Systems market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Fluorescence-Guided Surgery Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Fluorescence-Guided Surgery Systems market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Stryker, Hamamatsu Photonics, Medtronic, Quest Medical Imaging, Shimadzu, Fluoptics, KARL STORZ, Richard Wolf, OptoMedic, Mindray, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Fluorescence-Guided Surgery Systems market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Only for Open Surgery
System for Endoscopy
Market segment by Application
Cancer Surgeries
Cardiovascular Surgeries
Others
Major players covered
Stryker
Hamamatsu Photonics
Medtronic
Quest Medical Imaging
Shimadzu
Fluoptics
KARL STORZ
Richard Wolf
OptoMedic
Mindray
Olympus
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fluorescence-Guided Surgery Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Fluorescence-Guided Surgery Systems, with price, sales quantity, revenue, and global market share of Fluorescence-Guided Surgery Systems from 2020 to 2025.
Chapter 3, the Fluorescence-Guided Surgery Systems competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fluorescence-Guided Surgery Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fluorescence-Guided Surgery Systems market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Fluorescence-Guided Surgery Systems.
Chapter 14 and 15, to describe Fluorescence-Guided Surgery Systems sales channel, distributors, customers, research findings and conclusion.
Table of Contents
108 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Fluorescence-Guided Surgery Systems by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
